Accounts Submission

Company Accounts and Tax Online 07600875 Board of Directors 1.5.21 30.4.22 30.4.22 false iso4217:GBP xbrli:pure 07600875 2020-05-01 2021-04-30 07600875 2022-04-30 07600875 2021-05-01 2022-04-30 07600875 2021-04-30 07600875 countries:EnglandWales 2021-05-01 2022-04-30 07600875 curr:PoundSterling 2021-05-01 2022-04-30 07600875 uk-bus:PrivateLimitedCompanyLtd 2021-05-01 2022-04-30 07600875 uk-bus:Micro-entities 2021-05-01 2022-04-30 07600875 uk-bus:AuditExempt-NoAccountantsReport 2021-05-01 2022-04-30 07600875 uk-bus:FullAccounts 2021-05-01 2022-04-30 07600875 uk-bus:RegisteredOffice 2021-05-01 2022-04-30 07600875 uk-bus:Director1 2021-05-01 2022-04-30 07600875 uk-bus:Director1 2021-05-01 07600875 uk-bus:Director1 2022-04-30 07600875 uk-bus:Director2 2021-05-01 2022-04-30 07600875 uk-bus:Director2 2021-05-01 07600875 uk-bus:Director2 2022-04-30 07600875 uk-bus:Director3 2021-05-01 2022-04-30 07600875 uk-bus:Director3 2021-05-01 07600875 uk-bus:Director3 2022-04-30 07600875 core:AfterOneYear 2022-04-30 07600875 core:AfterOneYear 2021-04-30 07600875 core:WithinOneYear 2022-04-30 07600875 core:WithinOneYear 2021-04-30 07600875 core:WithinOneYear 2021-05-01 2022-04-30 07600875 core:AfterOneYear 2022-04-30 07600875 core:AfterOneYear 2021-04-30 07600875 core:AfterOneYear 2021-05-01 2022-04-30 07600875 core:ShareCapital 2022-04-30 07600875 core:ShareCapital 2021-04-30 07600875 core:RevaluationReserve 2022-04-30 07600875 core:RevaluationReserve 2021-04-30 07600875 core:RetainedEarningsAccumulatedLosses 2022-04-30 07600875 core:RetainedEarningsAccumulatedLosses 2021-04-30 07600875 1 2021-05-01 2022-04-30

Company Registration Number:
07600875 (England and Wales)

Unaudited micro entity accounts for the year ended 30 April 2022

Period of accounts

Start date: 01 May 2021

End date: 30 April 2022

Contents of the Financial Statements

for the Period Ended 30 April 2022


Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

Directors' Report Period Ended 30 April 2022

The directors present their report with the financial statements of the company for the period ended 30 April 2022

Principal Activities

The company's principal activity during the year continued to be that of research and development on biotechnology and medical diagnostics.

Political and charitable donations

No charitable or political donations were made.

Company policy on the employment of disabled persons

The company policy is to employ disabled people wherever practical. None of current staff members is registered disabled.

Additional information

None

Directors

The directors shown below have held office during the whole of the period from 01 May 2021 to 30 April 2022
Alexandre Loktionov
Tatiana Bandaletova
Olga Gandelman

This report was approved by the board of directors on 30 December 2022
And Signed On Behalf Of The Board By:

Name: Alexandre Loktionov
Status: Director

Profit and Loss Account

for the Period Ended 30 April 2022

	2022 £	2021 £
Turnover	0	0
Income from coronavirus (COVID-19) business support grants	22,467	1,600
Other Income	12,750	69,750
Cost of Materials	( 832 )	( 45,733 )
Staff Costs	( 28,431 )	( 53,144 )
Depreciation and Writeoffs	( 1,339 )	( 1,673 )
Other charges	( 0 )	( 0 )
Tax on Profit	( 0 )	7,632
Profit or (Loss) for Period	4,615	( 21,568 )

Balance sheet

As at 30 April 2022

	2022 £	2021 £
Called up share capital not paid:	0	0
Fixed Assets:	5,354	6,693
Current assets:	9,553	12,476
Prepayments and accrued income:	0	0
Creditors: amounts falling due within one year:	( 126,000 )	( 126,000 )
Net current assets (liabilities):	( 116,447 )	( 113,524 )
Total assets less current liabilities:	( 111,093 )	( 106,831 )
Creditors: amounts falling due after more than one year:	( 0 )	( 0 )
Provision for liabilities:	( 0 )	( 0 )
Accruals and deferred income:	( 0 )	( 0 )
Total net assets (liabilities):	( 111,093 )	( 106,831 )
Capital and reserves:	( 111,093 )	( 106,831 )

Balance sheet continued

For the year ending 30 April 2022 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 30 December 2022
And Signed On Behalf Of The Board By:

Name: Alexandre Loktionov
Status: Director

The notes form part of these financial statements

Footnotes to the Financial Statements

for the Period Ended 30 April 2022

1. Employee Information

Average number of employees: 2

Footnotes to the Financial Statements

for the Period Ended 30 April 2022

2. Off balance sheet disclosure

No

Accounts Submission